CN1092204C - 20(S)-人参皂甙Rg3的半合成方法及其药物用途 - Google Patents
20(S)-人参皂甙Rg3的半合成方法及其药物用途 Download PDFInfo
- Publication number
- CN1092204C CN1092204C CN98103433A CN98103433A CN1092204C CN 1092204 C CN1092204 C CN 1092204C CN 98103433 A CN98103433 A CN 98103433A CN 98103433 A CN98103433 A CN 98103433A CN 1092204 C CN1092204 C CN 1092204C
- Authority
- CN
- China
- Prior art keywords
- panaxoside
- group
- rgs
- virus
- ginsenoside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
瘤珠 | 分组 活细胞数 死细胞数 活细胞率 |
S180肉瘤 | 空白对照 6.1×105 0.62×105 91% |
阳性对照 1.0×105 1.0×105 50% | |
100μg/ml 3.5×105 2.25×105 61% | |
10μg/ml 4.5×105 1.6×105 74% | |
1μg/ml 4.25×105 2.25×105 65% | |
Lewis肺癌 | 空白对照 6.25×105 1.4×105 82% |
阳性对照 0.32×105 1.5×105 18% | |
100μg/ml 5.75×105 3.1×105 65% | |
10μg/ml 7.65×105 3.32×105 70% | |
1μg/ml 6.8×105 2.17×105 76% | |
B16黑色素瘤 | 空白对照 1.1×105 0.37×105 75% |
阳性对照 0.15×105 0.41×105 27% | |
100μg/ml 0.44×105 0.48×105 47% | |
10μg/ml 1.06×105 4.0×105 21% | |
1μg/ml 1.3×105 3.12×105 29% |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98103433A CN1092204C (zh) | 1998-07-28 | 1998-07-28 | 20(S)-人参皂甙Rg3的半合成方法及其药物用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98103433A CN1092204C (zh) | 1998-07-28 | 1998-07-28 | 20(S)-人参皂甙Rg3的半合成方法及其药物用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1243128A CN1243128A (zh) | 2000-02-02 |
CN1092204C true CN1092204C (zh) | 2002-10-09 |
Family
ID=5217907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98103433A Expired - Fee Related CN1092204C (zh) | 1998-07-28 | 1998-07-28 | 20(S)-人参皂甙Rg3的半合成方法及其药物用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1092204C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007006208A1 (fr) * | 2005-07-14 | 2007-01-18 | National Institute Of Pharmaceutical R & D Co., Ltd. | Composition médicinale contenant des glycosides secondaires de ginseng, procédé de préparation et application de celle-ci |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003252564A1 (en) * | 2003-08-18 | 2005-03-07 | Yuyu Inc. | A ginseng preparation using vinegar and process for thereof |
CN100390192C (zh) * | 2003-09-28 | 2008-05-28 | 中国科学院大连化学物理研究所 | 一种碱解天然人参皂苷制备单体低极性人参皂苷及其苷元的方法 |
CN1869048B (zh) * | 2006-06-21 | 2012-10-03 | 海南亚洲制药有限公司 | 一种从人参叶中提取分离f组人参皂苷的方法 |
KR101328620B1 (ko) * | 2006-07-18 | 2013-11-13 | 에스케이케미칼주식회사 | 신생혈관생성 억제용 조성물 |
CN103059089B (zh) * | 2013-01-25 | 2015-04-08 | 吉林省彩森仁生物科技有限责任公司 | 鲜葡萄汁催化下水解原人参二醇组皂苷制备次级人参皂苷Rg3的方法 |
CN104643058A (zh) * | 2013-11-21 | 2015-05-27 | 富力 | 20(R)-人参皂苷Rg3在制备改善或/和治疗肝硬化疾病的药物中的应用 |
CN103665081B (zh) * | 2013-12-06 | 2015-08-19 | 吉林大学 | 一种快速非热制备稀有人参皂甙Rg3(S)的方法 |
CN104688753B (zh) * | 2014-12-15 | 2018-09-14 | 中国农业科学院特产研究所 | 人参皂苷单体化合物在制备治疗黄病毒科病毒感染的药物中的用途 |
CN105777838A (zh) * | 2014-12-17 | 2016-07-20 | 富力 | 20(R)-人参皂苷Rg3衍生物、制备方法及其应用 |
CN106336445B (zh) * | 2016-07-28 | 2018-03-23 | 吉林农业大学 | 化合物20(R)‑人参皂苷Rg3的制备方法及应用 |
CN109438541A (zh) * | 2018-12-10 | 2019-03-08 | 吉林医药学院 | 新人参皂苷元hpd的半合成方法 |
CN111686104A (zh) * | 2020-07-01 | 2020-09-22 | 香港浸会大学深圳研究院 | 小白菊内酯、木犀草素、金圣草素和人参皂苷Rg3的新用途 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN86105166A (zh) * | 1985-07-22 | 1987-03-04 | 武田药品工业株式会社 | 生产人参皂甙-Rd的一种方法 |
CN1033278A (zh) * | 1987-11-24 | 1989-06-07 | 白求恩医科大学 | 人参皂甙Re单体生产工艺 |
CN1187353A (zh) * | 1996-03-26 | 1998-07-15 | 李敏 | 结核散及其制造方法 |
CN1190098A (zh) * | 1998-01-22 | 1998-08-12 | 白求恩医科大学基础医学院 | 人参分组皂甙的制备方法,其药物组合物及应用 |
-
1998
- 1998-07-28 CN CN98103433A patent/CN1092204C/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN86105166A (zh) * | 1985-07-22 | 1987-03-04 | 武田药品工业株式会社 | 生产人参皂甙-Rd的一种方法 |
CN1033278A (zh) * | 1987-11-24 | 1989-06-07 | 白求恩医科大学 | 人参皂甙Re单体生产工艺 |
CN1187353A (zh) * | 1996-03-26 | 1998-07-15 | 李敏 | 结核散及其制造方法 |
CN1190098A (zh) * | 1998-01-22 | 1998-08-12 | 白求恩医科大学基础医学院 | 人参分组皂甙的制备方法,其药物组合物及应用 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007006208A1 (fr) * | 2005-07-14 | 2007-01-18 | National Institute Of Pharmaceutical R & D Co., Ltd. | Composition médicinale contenant des glycosides secondaires de ginseng, procédé de préparation et application de celle-ci |
Also Published As
Publication number | Publication date |
---|---|
CN1243128A (zh) | 2000-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1092204C (zh) | 20(S)-人参皂甙Rg3的半合成方法及其药物用途 | |
CN1147766A (zh) | 治疗感染的药物 | |
WO2015030283A1 (ko) | 진세노사이드 성분이 증가된 가공인삼분말 또는 가공인삼추출물을 함유하는 암 관련 피로의 예방 및 치료용 조성물 | |
CN1990489A (zh) | 香豆草醚类化合物及其组合物的新用途 | |
JP6038486B2 (ja) | 台湾グリーンプロポリス抽出物を含む薬剤および栄養補給剤 | |
CN1891701A (zh) | 杂芳环缩氨基硫脲类化合物及其衍生物和它们在制备抗肿瘤药物中的应用 | |
CN1063957C (zh) | 一种金荞麦制剂的制备方法 | |
CN100342862C (zh) | 白藜芦醇低聚茋类化合物及其制法和其药物组合物与用途 | |
CN1290509C (zh) | 皂苷类化合物治疗心血管疾病的新用途 | |
CN1098707C (zh) | 含藻蛋白多糖提取物的药物组合物以及藻蛋白多糖的提取 | |
CN1199682C (zh) | 一种四逆散的有效部位及其制备方法 | |
CN1300160C (zh) | 人参皂苷次级苷compound K的脂肪酸酯类化合物及制备方法 | |
CN1109034C (zh) | 具抗癌活性的藤黄酸类化合物的复合物及其制备方法 | |
CN1895257A (zh) | 20(s)-原人参二醇在制备抗肠癌药物中的应用 | |
CN1313085C (zh) | 白首乌总苯乙酮及苯乙酮在制备治疗胃肠道疾病药物中的应用 | |
CN1600304A (zh) | 山葡萄提取物治疗炎症疾病的用途 | |
CN1660865A (zh) | 白首乌皂苷化合物、总皂苷及其在治疗胃肠道疾病药物中的应用 | |
CN106854223A (zh) | 氮芥槲皮素衍生物及其制备方法和用途 | |
TWI494113B (zh) | 台灣綠蜂膠萃取物用於減緩患者病情發展之用途 | |
CN101077873A (zh) | 新的neo-克罗烷型二萜化合物及其应用 | |
CN1199946C (zh) | 一种特异性吲哚类化合物及制备方法与其在治疗和预防癌症等疾病中的应用 | |
CN1055926C (zh) | 山油柑碱类似物、它们的制备方法及含这些化合物的药物组合物 | |
CN1281593C (zh) | 苯并异硒唑衍生物的免疫调节和生物治疗作用 | |
CN1600317A (zh) | 具有抗肿瘤活性的低极性人参皂苷组合物 | |
RU2704262C1 (ru) | Производные 2-аминохроменов проявляющие противоопухолевую активность. Фармацевтические композиции |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: JILIN UNIVERSITY SCHOOL OF BASE MEDICINE TECHNOLO Free format text: FORMER OWNER: BAIQIUEN MEDICINE UNIVERSITY BASE MEDICINE SCHOOL SCIENCE DEVELOPMENT CO., LTD. Owner name: BEIJING XINLIHENG MEDICAL TECHNOLOGY DEVELOPMENT Free format text: FORMER OWNER: BEIJING XINLIHENG MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD.; LI PINGYA; ZHAO WENJIE; WU JIAXIANG Effective date: 20020130 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20020130 Address after: 130021, Xinmin Avenue, Changchun, Jilin, 2 Applicant after: Basic Medical College Sci. & Tech. Dev. Center, Jilin Univ. Co-applicant after: Beijing Xinliheng Medicine Technology Development Co., Ltd., Beijing Address before: 130021, Xinmin Avenue, Changchun, Jilin, 2 Applicant before: Basic Medical College Science and Technology Development Company of Baiqiuen Medical University Co-applicant before: Beijing Xinliheng Medicine Technology Development Co., Ltd., Beijing Co-applicant before: Li Pingya Co-applicant before: Zhao Wenjie Co-applicant before: Wu Jiaxiang |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20021009 Termination date: 20170728 |